SVP and General Counsel Nicole R. Hadas sold $49K of Akebia Therapeutics, Inc.

Sold$48,513

$3.40Price

14,285Shares

−5%Stake

What AKBA did after the filing

Prices for AKBA after this filing aren't in yet.

Traded Mon, Mar 1. Filed Tue, Mar 2, 11:08 AM ET, during the session. Not investment advice.